drugset / Trial / NCT05331651

Summary

To compare the anti-nausea and vomiting effect between glycopyrronium in combination with tropisetron and normal saline in combination with tropisetron for patients receiving elective surgery under general anesthesia. Based on this study the investigators intend to explore the feasibility of using glycopyrronium as adjuvant drug to prevent postoperative nausea and vomiting.

Timeline

Start
2022-04-21
Primary completion
2023-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrronium Unknown 0.2 mg Intravenous
Background Tropisetron Small molecule 4 mg Intravenous

Indications

No indication recorded.